8-K
filed May 28, 2026, 9:01 AM ET
ticker VIR
CIK 0001706431
leadership
confidence high
sentiment neutral
materiality 0.65
Vir Biotechnology director Saira Ramasastry resigns; board shrinks to 7; annual meeting elects directors
Vir Biotechnology, Inc.
- Saira Ramasastry steps down from board and audit committee effective May 26, 2026, due to business conflict; no disagreement with company.
- Robert More appointed Audit Committee Chair; board size reduced from 8 to 7 upon Ramasastry's departure.
- At May 26 annual meeting, Class I directors Robert More, Janet Napolitano, and Elliott Sigal elected; Napolitano received 67.2M for, 54.5M withheld.
- Advisory vote on named executive officer compensation approved: 108.5M for, 11.9M against, 1.4M abstain.
- Ratification of Ernst & Young as independent auditor for FY2026 approved: 137.0M for, 0.15M against.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-26-038630
- form_type
- 8-K
- ticker
- VIR
- cik
- 0001706431
- company_name
- Vir Biotechnology, Inc.
- filed_at
- 2026-05-28T13:01:18+00:00
- discovered_at
- 2026-05-28T13:02:00.268108+00:00
- generated_at
- 2026-05-28T13:04:22.570135+00:00
- sec_items
- ["5.02", "5.07"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-26-038630
- json_url
- https://secwatch.observer/filing/0001628280-26-038630.json
- markdown_url
- https://secwatch.observer/filing/0001628280-26-038630.md
- text_url
- https://secwatch.observer/filing/0001628280-26-038630.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/0001628280-26-038630-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/vir-20260525.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GPOR
Gulfport Energy appoints Domenic Dell'Osso to Board; CEO role effective May 28, 2026
GULFPORT ENERGY CORP
June 1, 2026, 4:10 PM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Filing page
SEC filing
MGNO
Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair
Magnolia Bancorp, Inc.
June 1, 2026, 2:15 PM ET
leadership
Items 5.02, 5.07, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
Filing page
SEC filing
BELFA
Bel Fuse names Kenneth Lai as SVP ITDS; annual meeting approves 2026 equity plan
BEL FUSE INC /NJ
May 28, 2026, 2:24 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
on May 22, 2026, the Company determined to name Kenneth Lai as Senior Vice President ITDS, effective late second quarter or early third quarter of 2026. In this role, Mr. Lai’s responsibilities expand to include the Company’s India and private label operations, in addition to China and other Asia locations. As a result of this change in responsibilities, Mr. Lai is no longer determined to be an “executive officer” or “officer” of the Company as defined in Rules 3b-7 and 16a-1(f) under the Securities Exchange Act of 1934, as amended, respectively.
Filing page
SEC filing
HNST
The Honest Company promotes Curtiss Bruce to Chief Financial & Operating Officer and announces annual meeting results
Honest Company, Inc.
May 27, 2026, 4:35 PM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
On May 20, 2026, the Board of Directors of The Honest Company, Inc. (the “Company”) approved the promotion of Curtiss Bruce to the position of Chief Financial & Operating Officer, effective May 21, 2026 (the “Effective Date”).
Filing page
SEC filing
CRVL
CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026
CORVEL CORP
June 1, 2026, 5:05 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
Filing page
SEC filing
WTTR
Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named
Select Water Solutions, Inc.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,
Filing page
SEC filing
TTD
The Trade Desk appoints Nate Olmstead as CFO effective July 9, 2026; interim CFO Davis resumes CAO role
Trade Desk, Inc.
June 1, 2026, 4:35 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.
Filing page
SEC filing
WST
West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair
WEST PHARMACEUTICAL SERVICES INC
June 1, 2026, 4:32 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
Comparable filing
As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.